Atlas Trials

PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer

Clinical trial NCT00669292 · UNKNOWN

Trial details

NCT number
NCT00669292
Sponsor
Wakayama Medical University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2006-11-01
Primary completion
2009-11-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.